We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+8.1%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.28B
AUM Growth
+$1.61B
Cap. Flow
+$1.47B
Cap. Flow %
34.31%
Top 10 Hldgs %
18.89%
Holding
824
New
73
Increased
254
Reduced
178
Closed
177

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$89.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$85.1M
3
AMZN icon
Amazon
AMZN
+$53.1M
4
MSFT icon
Microsoft
MSFT
+$52.8M
5
META icon
Meta Platforms (Facebook)
META
+$49.2M

Sector Composition

Rank Sector Weight
1 Healthcare 17.14%
2 Financials 12.35%
3 Technology 12.23%
4 Communication Services 10.2%
5 Consumer Discretionary 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.81T
$130M 3.03%
4,934,432
+3,117,080
+172% +$89.1M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.24T
$116M 2.7%
2,970,540
+2,298,680
+342% +$85.1M
MSFT icon
3
Microsoft
MSFT
$2.95T
$104M 2.44%
1,883,293
+1,002,894
+114% +$52.8M
AMGN icon
4
Amgen
AMGN
$198B
$76.8M 1.8%
473,344
+228,154
+93% +$35.9M
AMZN icon
5
Amazon
AMZN
$2.66T
$72.4M 1.69%
2,143,440
+1,685,320
+368% +$53.1M
GILD icon
6
Gilead Sciences
GILD
$165B
$65.7M 1.54%
649,349
+389,321
+150% +$40.5M
META icon
7
Meta Platforms (Facebook)
META
$1.63T
$64.7M 1.51%
618,658
+478,500
+341% +$49.2M
LLY icon
8
Eli Lilly
LLY
$1.02T
$61.5M 1.44%
730,254
+425,101
+139% +$35.3M
DIS icon
9
Walt Disney
DIS
$167B
$59.9M 1.4%
570,238
+367,113
+181% +$40.9M
HD icon
10
Home Depot
HD
$332B
$57.8M 1.35%
436,873
+327,557
+300% +$41.7M
MA icon
11
Mastercard
MA
$484B
$53.7M 1.25%
551,540
+412,783
+297% +$40.4M
CMCSA icon
12
Comcast
CMCSA
$84.9B
$51.1M 1.19%
1,811,686
+1,292,130
+249% +$38.9M
KDP icon
13
Keurig Dr Pepper
KDP
$41.4B
$50M 1.17%
537,021
+256,606
+92% +$22.8M
UNH icon
14
UnitedHealth
UNH
$396B
$48.7M 1.14%
413,606
+199,662
+93% +$23.3M
CELG
15
DELISTED
Celgene Corp
CELG
$44.9M 1.05%
374,804
+259,849
+226% +$30.1M
XOM icon
16
ExxonMobil
XOM
$629B
$43.8M 1.02%
562,227
+84,961
+18% +$6.79M
NOC icon
17
Northrop Grumman
NOC
$74.4B
$42.4M 0.99%
224,798
+31,581
+16% +$5.79M
KR icon
18
Kroger
KR
$35.8B
$41.1M 0.96%
981,678
+659,429
+205% +$25.6M
JPM icon
19
JPMorgan Chase
JPM
$918B
$40.9M 0.96%
619,425
+2,746
+0.4% +$179K
CL icon
20
Colgate-Palmolive
CL
$72.4B
$39.5M 0.92%
592,706
+327,058
+123% +$21.8M
CAH icon
21
Cardinal Health
CAH
$52.9B
$39.4M 0.92%
441,328
+176,445
+67% +$15M
CVS icon
22
CVS Health
CVS
$137B
$39M 0.91%
398,639
+287,504
+259% +$28.2M
WFC icon
23
Wells Fargo
WFC
$261B
$36.1M 0.84%
664,380
+283,760
+75% +$15.4M
BAC icon
24
Bank of America
BAC
$430B
$35M 0.82%
2,080,610
+27,078
+1% +$458K
BR icon
25
Broadridge
BR
$17.4B
$35M 0.82%
651,663
+269,630
+71% +$15.1M

Similar funds

Boston Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, Boston Advisors held 824 positions worth $4.28B, up 60% from $2.67B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Advisors deployed $1.47B of net new capital in Q4 2015, opening 73 new positions and adding to 254 existing holdings. Its largest new stake was Helen of Troy: 237,650 shares worth $22.4M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $20.5M trimmed.

  • Boston Advisors's largest Q4 2015 buy was Helen of Troy: 237,650 shares worth $22.4M.
  • Boston Advisors added most to Apple in Q4 2015, an estimated $89.1M increase.
  • Boston Advisors's biggest Q4 2015 reduction was iShares Russell 2000 ETF, cutting an estimated $20.5M.
  • Boston Advisors fully exited Hasbro in Q4 2015, selling an estimated $11.9M.
  • Boston Advisors's ten largest holdings make up 19% of its $4.28B portfolio in Q4 2015.
  • Boston Advisors opened 73 new positions and closed 177 in Q4 2015.
  • Boston Advisors's portfolio value rose 60% quarter-over-quarter to $4.28B.

Based on Boston Advisors's 13F filing for Q4 2015, filed 20 Jan 2016.